New AI Platform Enhances Lung Cancer Patient Support at Chelsea and Westminster Hospital

Multilingual digital tool launched during Lung Cancer Awareness Month offers personalised guidance and information for patients undergoing diagnosis.

Generic image of a digital avatar representing a medical professional, with a subtle technological background.
AI

Generic image of a digital avatar representing a medical professional, with a subtle technological background.

Patients at Chelsea and Westminster Hospital undergoing diagnosis for possible lung cancer can now access a new AI-powered platform offering multilingual information and personalised guidance.

Launched during Lung Cancer Awareness Month, the Lung Cancer Digital Avatar Project (LCDAP), powered by OcciAI, has been developed by clinicians at the Trust to help patients better understand the tests, scans, and appointments involved in investigating suspected lung cancer.
The platform aims to support patients through their diagnostic journey by providing access to trusted information about their investigations. Patients can learn about upcoming procedures, revisit information after appointments, ask questions between consultations, and access support in their preferred language. Family members and carers can also use the resource.
It features short videos using AI-powered digital avatars representing members of the lung cancer multidisciplinary team to explain tests and what to expect. Additional resources include written information, animations, and an AI-supported question-and-answer function in patients' preferred language, drawing on trusted clinical resources.
Information is available in English and will initially be rolled out in the 10 most translated languages, designed to support people with different levels of health literacy and reduce language barriers. Patient involvement, in collaboration with the Roy Castle Lung Cancer Foundation, has been central to the development, with feedback shaping the design and content.
The project was supported by CW Innovation and funded by MSD. Clinicians hope the platform will improve patient understanding and confidence, reduce avoidable queries and missed appointments, and allow more clinical time to be focused on patients requiring additional support.
Based on information from the official source: Chelsea and Westminster Hospital NHS Foundation Trust (17/11/2026)